1-20 of 20
Keywords: cardiovascular risk
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Clin Sci (Lond) (2023) 137 (16): 1211–1224.
Published: 22 August 2023
...Helen Casey; Natalie Dennehy; Abigail Fraser; Christoph Lees; Carmel M. McEniery; Kayley Scott; Ian B. Wilkinson; Christian Delles The placental syndromes gestational hypertension, preeclampsia and intrauterine growth restriction are associated with an increased cardiovascular risk to the mother...
Clin Sci (Lond) (2019) 133 (21): 2221–2235.
Published: 13 November 2019
... platelet-activating factor acetylhydrolase PON paraoxonase RCT reverse cholesterol transport rHDL reconstituted HDL S1P sphingosine 1-phosphate SAA serum amyloid A SR-BI scavenger receptor B1 T2D Type 2 diabetes apolipoprotein A-I cardiovascular risk high...
Clin Sci (Lond) (2019) 133 (10): 1145–1166.
Published: 16 May 2019
... urinary TWEAK biomarkers cardiovascular risk diabetic kidney disease non-diabetic kidney disease TRAIL and OPG TWEAK References 1. Locksley R.M. , Killeen N. and Lenardo M.J. ( 2001 ) The TNF and TNF receptor superfamilies: integrating mammalian biology . Cell...
Clin Sci (Lond) (2015) 129 (1): 39–48.
Published: 01 April 2015
...Andreia Z. Chignalia; Maria Aparecida Oliveira; Victor Debbas; Randal O. Dull; Francisco R.M. Laurindo; Rhian M. Touyz; Maria Helena C. Carvalho; Zuleica B. Fortes; Rita C. Tostes The mechanisms whereby testosterone increases cardiovascular risk are not clarified. However, oxidative stress...
Includes: Supplementary data
Clin Sci (Lond) (2011) 120 (4): 153–160.
Published: 02 November 2010
... in a cohort of young adults (mean age 22 years) and their siblings participating in a longitudinal study of cardiovascular risk ( n =370). Insulin sensitivity was determined by euglycaemic insulin clamp. EDD (endothelium-dependent dilation) was determined by flow-mediated dilation using high-resolution...
Clin Sci (Lond) (2009) 116 (4): 273–282.
Published: 15 January 2009
... syndromes and other vascular complications. The principal goal of the present review is to evaluate the role of central BP measurements, principally systolic and pulse pressure, for cardiovascular risk assessment. Recent findings suggest that the pulsatile component of BP (when represented by central pulse...
Clin Sci (Lond) (2008) 114 (8): 561–566.
Published: 13 March 2008
...Vance A. Spence; Gwen Kennedy; Jill J. F. Belch; Alexander Hill; Faisel Khan Some of the symptoms reported by people with CFS (chronic fatigue syndrome) are associated with various cardiovascular phenomena. Markers of cardiovascular risk, including inflammation and oxidative stress, have been...
Clin Sci (Lond) (2008) 114 (6): 441–447.
Published: 12 February 2008
... of assessing arterial elasticity using the DC (distensibility coefficient) measured by TDI, the correlation of this with the DC obtained by other methods and the DC in patients with various degrees of cardiovascular risk. We studied 450 subjects (256 men; age, 51±10 years) with and without risk factors...
Clin Sci (Lond) (2008) 114 (4): 313–320.
Published: 15 January 2008
... were rigorously assessed by comprehensive transthoracic echocardiographic techniques in 229 patients with Type 2 diabetes. Cardiovascular risk factors and diabetic complications were assessed, and predictors of an abnormal echocardiogram were identified using multivariate logistic regression analysis...
Clin Sci (Lond) (2006) 111 (5): 341–347.
Published: 13 October 2006
... plibby@rics.bwh.harvard.edu ). 23 2 2006 2 6 2006 19 7 2006 19 7 2006 The Biochemical Society 2006 assay interference cardiovascular risk CD40 ligand (CD40L) cytokine soluble CD40L Comparison of serum and plasma (platelet-free) samples from 20 donors...
Clin Sci (Lond) (1994) 87 (2): 201–206.
Published: 01 August 1994
...). These patients were later ran- Key words: body composition, body fat, cardiovascular risk, growth hormone deficiency, insulin, muscle mass, obesity. Abbreviations: BMI, body mass index; G H , growth hormone; GHD. growth hormone deficiency. Correspondence: Dr Franco Salomon. Medirinirche Klinik, Departement fur...
Clin Sci (Lond) (1993) 85 (2): 219–222.
Published: 01 August 1993
... patients. 26 3 1993 15 4 1993 © 1993 The Biochemical Society and the Medical Research Society 1993 acute-phase proteins cardiovascular risk hypertriglyceridaemia sialic acid Clinical Science (1993) 85, 219-222 (Printed in Great Britain) Serum sialic acid and acute-phase...
Clin Sci (Lond) (1992) 83 (5): 593–595.
Published: 01 November 1992
...M. Crook; P. Tutt 1. Serum total sialic acid concentration, recently shown to be a cardiovascular risk factor, and also serum lipid-associated sialic acid concentration were measured in 15 patients with hypertriglyceridaemia (fasting serum triacylglycerol concentration > 2.3 mmol/l) showing...